Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 7/10/23 → 7/10/27 |
Financiación
- Legend Biotech USA Incorporated: 500.433,00 US$
23-LUN-133-LB-PMC: LB2102-1001, A First in Human Dose Escalation and Cohort Expansion Study of DLL3-directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
- Hao, Zhonglin (PI)